Cosmetics

China’s NIFDC releases 6 new technical guidelines for high-risk cosmetics, impacting hair dye, perming, and sunscreen product compliance.

Hong Kong confirms injectable products are generally classified as pharmaceutical products under Cap. 138, impacting medical aesthetics and borderline products

TFDA eliminates legacy cosmetics review fees, reducing compliance costs for foreign companies.

Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.

China’s NMPA has opened consultation on a draft mandatory toothpaste safety standard that could tighten product requirements.

China NMPA adds four new cosmetic testing methods effective July 2026, impacting compliance and safety assessment strategies.

China’s NMPA updates cosmetics testing methods, adding CBD detection and tighter impurity controls impacting global compliance.

Indonesia’s BPOM has strengthened clinical trial approval procedures and introduced detailed requirements for cosmetic clinical trials.

Vietnam’s MoH recently published Circular drops several healthcare advertising regulations and streamlines requirements for many categories.

Vietnam’s draft cosmetic management decree would replace existing rules and strengthen post-market controls for cosmetic companies.

NPRA Circular No. 1/2026 updates Malaysia’s cosmetic ingredient annexes to align with the ASEAN Cosmetic Directive

China’s NMPA is incorporating 18 revised cosmetics standards into the Safety and Technical Standards for Cosmetics.